ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for discussion Regístrate para interactuar en nuestros foros activos para discutir con inversores de ideas afines.

MNKD MannKind Corporation

4.23
0.05 (1.20%)
26 Abr 2024 - Cerrado
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
MannKind Corporation MNKD NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
0.05 1.20% 4.23 16:33:40
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
4.20 4.15 4.365 4.23 4.18
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
03/4/202405:00GLOBEMannKind Repays Certain Debt Obligations
26/3/202415:05GLOBEMannKind Announces CFO Transition
11/3/202405:05GLOBEINHALE-3 Study’s Initial Meal Challenge Results Comparing..
05/3/202405:05GLOBEMannKind Announces New Clinical Data From Inhale-3 Study to..
04/3/202412:01GLOBEMannKind Corporation Announces Participation at Upcoming..
27/2/202415:05EDGAR2Form 8-K - Current report
27/2/202415:00GLOBEMannKind Corporation Reports 2023 Fourth Quarter and Full..
20/2/202405:00GLOBEMannKind Corporation to Hold 2023 Fourth Quarter and Full..
15/2/202405:05GLOBEMannKind Announces Enrollment Goal Completion of INHALE-1..
05/2/202405:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/2/202405:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/2/202405:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/2/202405:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/2/202405:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/1/202405:06EDGAR2Form 8-K - Current report
02/1/202405:05GLOBEMannKind and Sagard Healthcare Enter Into Royalty Purchase..
28/12/202305:00GLOBEMannKind Corporation to Present at 42nd Annual J.P. Morgan..
27/12/202315:15EDGAR2Form 8-K - Current report
15/12/202320:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/12/202315:09EDGAR2Form 144 - Report of proposed sale of securities
14/12/202318:56EDGAR2Form 144 - Report of proposed sale of securities
14/12/202315:08EDGAR2Form 144 - Report of proposed sale of securities
07/11/202315:05EDGAR2Form 8-K - Current report
07/11/202315:00GLOBEMannKind Corporation Reports 2023 Third Quarter Financial..
06/11/202305:15GLOBEMannKind Announces Completion of Enrollment in U.S. Phase 4..
02/11/202320:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/11/202320:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/11/202318:07EDGAR2Form 144 - Report of proposed sale of securities
31/10/202315:00GLOBEMannKind Corporation to Hold 2023 Third Quarter Financial..
30/10/202305:15GLOBEMannKind Expands Patent Portfolio With New Clofazimine..
03/10/202320:00EDGAR2Form 4/A - Statement of changes in beneficial ownership of..
02/10/202320:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/10/202316:51EDGAR2Form 144 - Report of proposed sale of securities
05/9/202320:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/9/202305:00GLOBEMannKind Corporation Announces Participation at Upcoming..
01/9/202315:11EDGAR2Form 144 - Report of proposed sale of securities
28/8/202320:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/8/202320:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/8/202320:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/8/202320:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/8/202317:45EDGAR2Form 144 - Report of proposed sale of securities
23/8/202315:52EDGAR2Form S-8 - Securities to be offered to employees in employee..
07/8/202315:06EDGAR2Form 8-K - Current report
07/8/202315:00GLOBEMannKind Corporation Reports 2023 Second Quarter Financial..
01/8/202320:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/8/202317:30EDGAR2Form 144 - Report of proposed sale of securities
01/8/202305:00GLOBEMannKind Corporation Announces Participation in the 2023..
31/7/202315:00GLOBEMannKind Corporation to Hold 2023 Second Quarter Financial..
05/7/202305:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/6/202305:05GLOBEMannKind Launches Inhale-3 Study to Address the Most..

Su Consulta Reciente

Delayed Upgrade Clock